Capricor Therapeutics (CAPR) Shares Outstanding (2010 - 2026)

Capricor Therapeutics' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $23.1 million for Q4 2021.

• On a quarterly basis, Shares Outstanding (Entity) rose 48.28% year-over-year to $23.1 million in Q4 2021; TTM through Dec 2021 was $23.1 million, a 48.28% increase from a year earlier, with the FY2021 full-year figure at $23.1 million, up 48.28% from the prior year.
• Shares Outstanding (Entity) was little changed at $23.1 million in Q4 2021 per CAPR's latest filing, from $23.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $23.1 million in Q3 2021 and bottomed at $2.1 million in Q1 2017.
• The 5-year median for Shares Outstanding (Entity) is $3.6 million (2019), against an average of $9.3 million.
• Across the five-year window, Shares Outstanding (Entity) soared 384.13% in 2020 and increased 14.27% in 2021, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $2.6 million in 2017, then rose by 19.48% to $3.1 million in 2018, then gained by 18.24% to $3.7 million in 2019, then jumped by 319.55% to $15.6 million in 2020, then jumped by 48.28% to $23.1 million in 2021.
• Per Business Quant, the three latest CAPR Shares Outstanding (Entity) figures stand at $23.1 million (Q4 2021), $23.1 million (Q3 2021), and $23.0 million (Q2 2021).